1-May-2026
Stifel Nicolaus Sticks to Its Buy Rating for Clarivate (CLVT)
TipRanks (Thu, 30-Apr 11:26 AM ET)
RBC Capital Reaffirms Their Hold Rating on Clarivate (CLVT)
TipRanks (Thu, 30-Apr 7:56 AM ET)
Barclays Sticks to Their Sell Rating for Clarivate (CLVT)
TipRanks (Thu, 30-Apr 4:57 AM ET)
Clarivate Earnings Call: Margins Up, Growth Still Cautious
TipRanks (Wed, 29-Apr 8:52 PM ET)
TipRanks (Wed, 29-Apr 4:20 PM ET)
Seeking Alpha News (Wed, 29-Apr 1:22 PM ET)
Clarivate Reports Q1 2026 Results, Reaffirms 2026 Outlook
TipRanks (Wed, 29-Apr 6:33 AM ET)
Clarivate Analytics beats top-line and bottom-line estimates; introduces FY26 outlook
Seeking Alpha News (Wed, 29-Apr 6:10 AM ET)
Clarivate Reports First Quarter 2026 Results
PRNewswire (Wed, 29-Apr 6:00 AM ET)
Clarivate Analytics Q1 2026 Earnings Preview
Seeking Alpha News (Tue, 28-Apr 11:20 AM ET)
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.
Clarivate PLC trades on the NYSE stock market under the symbol CLVT.
As of May 1, 2026, CLVT stock price declined to $2.79 with 8,193,563 million shares trading.
CLVT has a beta of 2.19, meaning it tends to be more sensitive to market movements. CLVT has a correlation of 0.21 to the broad based SPY ETF.
CLVT has a market cap of $1.78 billion. This is considered a Small Cap stock.
Last quarter Clarivate PLC reported $586 million in Revenue and $.18 earnings per share. This beat revenue expectation by $16 million and exceeded earnings estimates by $.04.
In the last 3 years, CLVT traded as high as $10.03 and as low as $1.66.
The top ETF exchange traded funds that CLVT belongs to (by Net Assets): AVUV, FXL, VXF, DFAT, DFSV.
CLVT has underperformed the market in the last year with a return of -35.0%, while SPY returned +30.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CLVT shares. However, CLVT has outperformed the market in the last 3 month and 2 week periods, returning +5.3% and +4.1%, while SPY returned +4.4% and +1.5%, respectively. This indicates CLVT has been having a stronger performance recently.
CLVT support price is $2.73 and resistance is $3.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLVT shares will trade within this expected range on the day.